Bausch Health Companies Inc. · TSX:BHC
Bausch Health Companies — Shareholder Meeting (April 2020)
18 slides from Bausch Health Companies's shareholder meeting presentation, Apr 28, 2020
Slide 1: 2020 Annual Meeting of Shareholders
Exhibit 99.1 2020 Annual Meeting of Shareholders April 28, 2020
Slide 2: Forward-Looking Statements
Forward-Looking Statements This presentation contains forward-looking information and statements, within not limited to, risks and uncertainties caused by or relating to the evolving the meaning of applicable securities laws (collectively, “forward-looking COVID-19 pandemic, and the fear of that pan
Slide 3: Non-GAAP Information
Non-GAAP Information To supplement the financial measures prepared in accordance with U.S. generally accepted accounting principles (GAAP), the Company uses certain non-GAAP financial measures, including Organic Revenue Growth. Management uses non-GAAP measures as key metrics in the evaluation of co
Slide 4: Introductions: Board of Directors
Introductions: Board of Directors Joseph C. Papa Thomas W. Ross, Sr. Richard U. De Schutter D. Robert Hale Argeris (Jerry) N. Sarah B. Kavanagh Chairman Karabelas John A. Paulson Robert N. Power Russel C. Robertson Andrew C. Dr. Amy B. von Eschenbach, M.D Wechsler 3
Slide 5: Remarks from Chairman & CEO Joseph C. Papa
Remarks from Chairman & CEO Joseph C. Papa 2020 Annual Meeting of Shareholders April 28, 2020 4
Slide 6: Impact on the World Today
Impact on the World Today Every day more than 150 million people around the world use a Bausch Health product 5
Slide 7: Our Vision, Mission and Values
Our Vision, Mission and Values Our Vision: Core Values: To Be Your Trusted • Accountability Health Care Partner • Agility • Courage • Integrity • Teamwork • Results Orientation Our Mission: Improving People’s Lives With Our Health Care Products 6
Slide 8: 2019: Pivot to Offense
2019: Pivot to Offense FY19 Reported Revenue: +3% FY19 Organic Revenue1,2: +4% Key Drivers in 2019 Additional Highlights • Bausch + Lomb/ International reported 2% revenue • $1,501M of cash generated from operations during growth and 5% organic revenue growth1,2 for full 2019 year 2019 driven by: •
Slide 9: New Products Producing Results
New Products Producing Results • Following the launch of Thermage® FLX in Asia Pacific, the franchise saw 70% reported revenue growth and 73% organic revenue growth1,2 vs. FY18 • Thermage® is now a top 10 Bausch Health franchise • $63M in revenue for FY19 • Achieved weekly market share of ~43%3 • #1
Slide 10: COVID-19 Update
COVID-19 Update 9
Slide 11: COVID-19: Impacts and Actions
COVID-19: Impacts and Actions Employees Supply Chain Liquidity • Health and safety of our employees • Objective: maintain uninterrupted • BHC is in a strong position from a is paramount. Senior management availability of our products to meet liquidity standpoint continues to assess situation and nee
Slide 12: COVID-19: How Bausch Health is Helping
COVID-19: How Bausch Health is Helping “In line with our mission of improving people's lives with our health care products, we will continue to seek opportunities to offer support and aid to the institutions, patients and health care providers battling this pandemic.” Providing Medicines and Supplie
Slide 13: Closing Remarks
Closing Remarks BAUSCH Health
Slide 14: Bausch Health 20/20 Vision: Global, Diversified, Durable
Bausch Health 20/20 Vision: Global, Diversified, Durable Diverse Company • Only one product accounts for >5% of revenue • Diversified by revenue type (Rx, OTC, devices) and geography • Independently strong businesses Global Footprint • Operating in ~100 countries around the world • Opportunity to gl
Slide 15: Question & Answer Period
Question & Answer Period BAUSCH Health
Slide 16: Appendix
Appendix 15
Slide 17: Reconciliation of Reported Growth to Organic Growth ($M)
Reconciliation of Reported Growth to Organic Growth ($M) Calculation of Organic Revenue Twelve Months Ended Twelve Months Ended Change in December 31, 2019 December 31, 2018 Organic Revenue Revenue as Changes in Organic Revenue Revenue as Divestitures and Organic Revenue Reported Exchange Rates (a)
Slide 18: Non-GAAP Appendix: Description of Non-GAAP Financial Measures
Non-GAAP Appendix Description of Non-GAAP Financial Measures Description of Non-GAAP Financial Measures Organic revenue growth reflects adjustments for: (i) the impact of Organic Revenue Growth period-over-period changes in foreign currency exchange rates on To supplement the financial measures prep
Bausch Health Companies — Shareholder Meeting (April 2020) on 6ix